| 9861/13381 | US=84 / Biol/Mol Band A, Laiho M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 243-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-BETA; SMAD; TRANSDUCAO DE SINAL; SNON; PROTEASSOMA; UBIQUITINA; SUMO; DEGRADACAO |
| 9862/13381 | US=84 / Biol/Mol Thuault S, Valcourt U, Kowanetz M, Moustakas A. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B and smad signaling in transcriptome reprogramming during EMT. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 259-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ADERENTES JUNCAO; EMT; METASTASE; POLARIDADE; JUNCAO APERTADA |
| 9863/13381 | US=84 / Biol/Mol Stuelten CH, Roberts AB, Stetler-Stevenson WG. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: functional interactions between MMPs and TGF-B in normal and tumor tissue. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 275-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; MMP; TUMOR; INTERACAO ESTROMA TUMORAL; SINALIZACAO CELULAR |
| 9864/13381 | US=84 / Biol/Mol Liu IM, Schilling SH, Wang XF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: Cooperation between TGF-B and Wnt pathway components in regulating mesenchymal stem cell function. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 293-303. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CELULAS-TRONCO MESENQUIMAIS; SMAD3; B-CATENINA; CROSSTALK; PROLIFERACAO; DIFERENCIACAO |
| 9865/13381 | US=84 / Biol/Mol Glick A, Bae DS, Liu X, Vijayachandra K. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: interaction of oncogenic ras and TGFB1 signaling in cancer: lessons from the multistage skin carcinogenesis model. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 305-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGFB1; ONCOGENE RAS; PELE; QUERATINOCITOS; VARIOS ESTAGIOS DA CARCINOGENESE; CANCER DE PELE |
| 9866/13381 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |
| 9867/13381 | US=84 / Biol/Mol MacLaughlin DT, Donahoe PK. TGF-B superfamily members in normal and tumor biology: mullerian inhibiting substance: a potencial nontoxic, naturally occurring therapeutic agent for certain human cancers. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 333-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 9868/13381 | US=84 / Biol/Mol Hayashida T, Gupta V, Thiagalingam S, Maheswaran S. TGF-B superfamily members in normal and tumor biology: activins, inhibins, and bone morphogenetic proteins as modulators and biomarkers of prostate cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 355-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CANCER DE PROSTATA; ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 9869/13381 | US=84 / Biol/Mol Berberian G, Malhotra D, Langenfeld JE. TGF-B superfamily members in normal and tumor biology: bone morphogenic proteins and angiogenesis in developing tumors. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 373-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 9870/13381 | US=84 / Biol/Mol Leader JE, Frontelo MP, Lechleider RJ. TGF-B superfamily members in normal and tumor biology: histone methyltransferase and smad interactions in BMP signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 383-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. HISTONA METILTRANSFERASE; SMAD; BMP; RECEPTORES DE CELULAS DE SUPERFICIE; FAMILIA SUV39H; CROMATINA |
| 9871/13381 | US=84 / Biol/Mol Fonsatti E, Maio M. TGF-B superfamily members in normal and tumor biology: endoglin (CD105): a strong candidate for immunologic targeting of tumor neovasculature in human malignancies. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 395-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ENDOGLINA; CD105; ANGIOGENESE; CARCINOGENESE; CELULAS ENDOTELIAIS; VASCULAR ALVO |
| 9872/13381 | US=84 / Biol/Mol Risbridger GP, Butler C. TGF-B superfamily members in normal and tumor biology: activins and cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 411-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. INIBIDORES; ACTIVINA; TUMORIGENESE; X SUBUNIDADE; SUBUNIDADE BA; METASTASE; ANGIOGENESE; SUPRESSAO IMUNITARIA |
| 9873/13381 | US=84 / Biol/Mol Mazerbourg S. TGF-B superfamily members in normal and tumor biology: bone morphogenetic proteins/growth differentiation factors and smad activation in ovarian granulosa cells and carcinoma. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 425-50. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; BMP; GDF; SMAD; TGF-B RECEPTOR; CANCER NO OVARIO; OVARIO; CELULAS DA GRANULOSA; VIA DE SINALIZACAO |
| 9874/13381 | US=84 / Biol/Mol López-Casillas F, Vilchis-Landeros MM, Esparza-López J, Ponce-Castañeda MV, Velasco-Loyden NG, Juárez P, Montiel JL, Mendoza V. TGF-B superfamily members in normal and tumor biology: regulation of the transforming growth factor-B superfamily by betaglycan. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 451-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B TIPO III RECEPTOR; TGF-B; TGF-B INIBIDORES; TUBERCULOSE; BETAGLICAM; BETAGLICAM NULOS RATOS; ECOTODOMAIN DERRAMAMENTO; DESENVOLVIMENTO CABECA; INIBINA; NEFROPATIAS; XENOGRAFS TUMORAIS |
| 9875/13381 | US=84 / Biol/Mol Yanagita M. TGF-B superfamily members in normal and tumor biology: uterine sensitization associated gene-1: a bone morphogenetic protein antagonist with a role in kidney. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 463-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 9876/13381 | US=84 / Biol/Mol Zhao Y, Hei TK. TGF-B superfamily members in normal and tumor biology: role of betaig-h3 gene in carcinogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 475-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. BETAIG-H3; CARCINOGENESE; DISTROFIAS DE CORNEA; METILACAO; PROLIFERACAO; APOPTOSE; ANTITUMORAL |
| 9877/13381 | US=84 / Biol/Mol Grusch M, Rodgarkia-Dara C, Bursch W, Schulte-Hermann R. TGF-B superfamily members in normal and tumor biology: activins and the liver. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 483-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; ATIVINAS; INIBINA; FOLLISTATINS; APOPTOSE HEPATICA; SINTESE DE ADN HEPATICO; EFEITOS INFLAMATORIOS; FIBROSE HEPATICA; MITOGENOS QUIMICOS; TUMORES HEPATICOS |
| 9878/13381 | US=84 / Biol/Mol Zhu X, Liang LF, Stotish RL. TGF-B superfamily members in normal and tumor biology: myostatin signaling in normal and tumor cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 509-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. SMAD; MIOSTATINA; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; MUSCULO ESQUELETICO; VIA DE SINAL; TECIDO ADIPOSO; TUMORES RABDOMIOSSARCOMA |
| 9879/13381 | US=84 / Biol/Mol Suh N. TGF-B in inflammation and fibrosis: triterpenoids, vitamina D, and TGF-B/smad signaling in inflammation and cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 525-47. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 9880/13381 | US=84 / Biol/Mol Murphy-Ullrich JE. TGF-B in inflammation and fibrosis: thrombospondin-dependent activation of latent TGF-B in fibrosis and disease. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 549-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CANCER; TROMBOSPONDINA; LATENTE TGF-B; ATIVACAO; FIBROSE; CICATRIZACAO DE FERIDAS |